You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Systemic lupus erythematosus

Obinutuzumab with immunosuppressive therapies for treating lupus nephritis [ID6420]

  • In development
  • Reference number: GID-TA11478
  • Expected publication date:  11 March 2026
  • Project information
  • Project documents

NIHRIO BN: 11864-Obinutuzumab-Mycophenolate-Mofetil-for-Lupus-Nephritis-V1.0-OCT2023-NON-CONF.pdf (nihr.ac.uk)

Back to top